End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.165 CHF | -6.05% | -10.38% | -41.46% |
Apr. 30 | Relief Therapeutics Holding SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 30 | Relief Therapeutics' FY23 Loss Widens; Revenue Edges Down | MT |
Sales 2022 | 6.08M 6.72M | Sales 2023 | 6.33M 6.99M | Capitalization | 24.96M 27.56M |
---|---|---|---|---|---|
Net income 2022 | -50M -55.22M | Net income 2023 | -98M -108M | EV / Sales 2022 | 19.3 x |
Net cash position 2022 | 14.89M 16.45M | Net cash position 2023 | 11.6M 12.81M | EV / Sales 2023 | 2.11 x |
P/E ratio 2022 |
-2.5
x | P/E ratio 2023 |
-0.24
x | Employees | 69 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.87% |
1 day | -6.05% | ||
1 week | -10.38% | ||
Current month | -6.05% | ||
1 month | -11.07% | ||
3 months | -31.15% | ||
6 months | -40.26% | ||
Current year | -41.46% |
Managers | Title | Age | Since |
---|---|---|---|
Michelle Lock
CEO | Chief Executive Officer | - | 22-01-27 |
Jeremy Meinen
DFI | Director of Finance/CFO | - | - |
Ram Selvaraju
CHM | Chairman | 46 | 16-05-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Selvaraju
CHM | Chairman | 46 | 16-05-24 |
Paolo Galfetti
COO | Chief Operating Officer | - | 21-05-26 |
Thomas Plitz
BRD | Director/Board Member | 56 | 20-12-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1.165 | -6.05% | 61,152 |
24-05-02 | 1.24 | 0.00% | 3,354 |
24-04-30 | 1.24 | -4.62% | 13,714 |
24-04-29 | 1.3 | 0.00% | 6,208 |
24-04-26 | 1.3 | +4.00% | 1,665 |
End-of-day quote Swiss Exchange, May 02, 2024
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.46% | 16.15M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- RLF Stock